DK3846783T3 - Nanopartikler omfattende tacrolimus - Google Patents

Nanopartikler omfattende tacrolimus Download PDF

Info

Publication number
DK3846783T3
DK3846783T3 DK19816295.0T DK19816295T DK3846783T3 DK 3846783 T3 DK3846783 T3 DK 3846783T3 DK 19816295 T DK19816295 T DK 19816295T DK 3846783 T3 DK3846783 T3 DK 3846783T3
Authority
DK
Denmark
Prior art keywords
tacrolimus
nanoparticles
Prior art date
Application number
DK19816295.0T
Other languages
English (en)
Inventor
Wolfgang Beier
Elke Horstkotte
Original Assignee
Nucleus Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucleus Medical Gmbh filed Critical Nucleus Medical Gmbh
Application granted granted Critical
Publication of DK3846783T3 publication Critical patent/DK3846783T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5138Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5161Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK19816295.0T 2018-12-04 2019-12-04 Nanopartikler omfattende tacrolimus DK3846783T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102018130848 2018-12-04
PCT/EP2019/083691 WO2020115140A1 (en) 2018-12-04 2019-12-04 Nanoparticles comprising tacrolimus

Publications (1)

Publication Number Publication Date
DK3846783T3 true DK3846783T3 (da) 2024-01-15

Family

ID=68766584

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19213120.9T DK3662894T3 (da) 2018-12-04 2019-12-03 Nanopartikler omfattende tacrolimus
DK19816295.0T DK3846783T3 (da) 2018-12-04 2019-12-04 Nanopartikler omfattende tacrolimus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK19213120.9T DK3662894T3 (da) 2018-12-04 2019-12-03 Nanopartikler omfattende tacrolimus

Country Status (18)

Country Link
US (2) US11311479B2 (da)
EP (2) EP3662894B1 (da)
JP (1) JP2022513697A (da)
KR (1) KR20210100142A (da)
CN (1) CN113242732A (da)
AU (1) AU2019392718A1 (da)
CA (1) CA3063417C (da)
DK (2) DK3662894T3 (da)
ES (2) ES2894112T3 (da)
FI (1) FI3846783T3 (da)
HR (1) HRP20240072T1 (da)
HU (2) HUE056067T2 (da)
IL (1) IL283458A (da)
PL (2) PL3662894T3 (da)
PT (1) PT3846783T (da)
SG (1) SG11202105778PA (da)
SI (2) SI3662894T1 (da)
WO (1) WO2020115140A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113425716A (zh) * 2021-05-27 2021-09-24 南京诺亚药业有限公司 一种他克莫司药物组合物及其制备方法
EP4104816A1 (en) * 2021-06-14 2022-12-21 Nucleus Medical GmbH Non-nanoparticulate applications forms of macrolides
AU2023232910A1 (en) * 2022-03-11 2024-09-12 Lts Lohmann Therapie-Systeme Ag Transmucosal therapeutic system containing a macrolide immunosuppressant
WO2024052883A1 (en) * 2022-09-10 2024-03-14 Pattanaik Smita Buccomucoadhesive patch-based drug delivery system for tacrolimus
EP4410287A1 (en) * 2023-02-06 2024-08-07 Nucleus Medical GmbH A macrolide for use in a method of preventing or treating an immunological disease or disorder
WO2024165562A1 (en) * 2023-02-06 2024-08-15 Nucleus Medical Gmbh A macrolide for use in a method of preventing or treating an immunological disease or disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004264974A1 (en) * 2003-08-15 2005-02-24 Arius Two, Inc. Adhesive bioerodible transmucosal drug delivery system
EA013741B1 (ru) * 2004-12-15 2010-06-30 Элан Фарма Интернэшнл Лтд. Дисперсии наночастиц такролимуса с повышенными растворимостью в воде и биодоступностью, способы их приготовления и применения
WO2009022354A2 (en) * 2007-03-29 2009-02-19 Panacea Biotec Limited. Modified dosage forms of tacrolimus
WO2012026896A1 (en) * 2010-08-25 2012-03-01 Les Laboratoires Medis Sa Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof
CA2901948A1 (en) * 2013-02-21 2014-08-28 Massachusetts Institute Of Technology Targeted buccal delivery of agents
EP3270891A1 (en) * 2015-03-17 2018-01-24 Leon-Nanodrugs GmbH Nanoparticles comprising a stabilized boronic acid compound
DE102016101232A1 (de) 2016-01-25 2017-07-27 Instillo Gmbh Verfahren zum Herstellen von Emulsionen

Also Published As

Publication number Publication date
JP2022513697A (ja) 2022-02-09
US20220079872A1 (en) 2022-03-17
DK3662894T3 (da) 2021-09-20
HUE056067T2 (hu) 2022-01-28
SI3662894T1 (sl) 2021-11-30
EP3662894A1 (en) 2020-06-10
IL283458A (en) 2021-07-29
ES2894112T3 (es) 2022-02-11
HRP20240072T1 (hr) 2024-05-10
WO2020115140A1 (en) 2020-06-11
AU2019392718A1 (en) 2021-06-10
CA3063417C (en) 2023-01-03
US11904048B2 (en) 2024-02-20
SI3846783T1 (sl) 2024-03-29
EP3846783A1 (en) 2021-07-14
EP3846783B1 (en) 2023-10-18
EP3662894B1 (en) 2021-07-28
US20200170934A1 (en) 2020-06-04
HUE065588T2 (hu) 2024-06-28
PL3846783T3 (pl) 2024-04-02
PT3846783T (pt) 2024-01-19
FI3846783T3 (fi) 2024-01-15
CN113242732A (zh) 2021-08-10
KR20210100142A (ko) 2021-08-13
PL3662894T3 (pl) 2022-01-10
US11311479B2 (en) 2022-04-26
ES2969096T3 (es) 2024-05-16
EP3846783B8 (en) 2023-11-22
CA3063417A1 (en) 2020-06-04
SG11202105778PA (en) 2021-06-29

Similar Documents

Publication Publication Date Title
DK3627029T3 (da) Manipulationssikret låg
DE202018003363U8 (de) Handgelenkssphygmomanometer
CL2018001630S1 (es) Automóvil
CL2018000524S1 (es) Golilla
FIC20240013I1 (fi) Lebrikitsumabi
DK3351526T3 (da) Diisopentylterephthalat
DK3846783T3 (da) Nanopartikler omfattende tacrolimus
DK3513569T3 (da) Øretelefon
DK3568655T3 (da) Rekuperator
DK3571580T5 (da) Load-logical-and-shift-guarded-instruktion
DK3612237T3 (da) Genterapi
DK3568506T3 (da) Offeranode
IT201700032614A1 (it) Veicolo
CL2018000577S1 (es) Automóvil
DK3576686T3 (da) Brokbind
DE102017126475A8 (de) Fahrzeug
DK3676276T3 (da) Spirothietannukleosider
DK3625112T3 (da) Multimodalt køretøj
DK3395159T3 (da) Ballepresse
DK3576718T3 (da) Pastil
DK3510051T3 (da) Carboxylalkylchitosan
CL2018001373S1 (es) Automóvil
DK3391733T3 (da) Ballepresse
DK3645955T3 (da) Buffertank
DK3401461T3 (da) Falsetagtegl